Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in combination with anti CD20 antibodies or chemotherapeutics

Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in combination with anti CD20 antibodies or chemotherapeutics

US Patent 11634488 · Granted Apr 25, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD5 antibodies and methods of use thereof2024
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation prof2022
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies2020
Anti-CK8 antibodies for use in the treatment of colorectal cancers2020
Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation prof2017
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies2017
Anti-CD19 antibody having ADCC function with improved glycosylation profile2015